Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)
China · Delayed Price · Currency is CNY 6.12
0.00 (0.00%)
Oct 23, 2026, 3:04 PM CST
SHE:002107 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 781.18 | 816.95 | 763.79 | 909.51 | 1,015 | 942.67 |
Revenue Growth | -3.76% | 6.96% | -16.02% | -10.38% | 7.65% | -6.30% |
Gross Profit Gross Profit Growth | 601.88 | 613.89 | 552.97 | 674.76 | 759.55 | 727.74 |
Operating Income Operating Income Growth | 130.02 | 89.43 | 37.06 | 47.05 | 101.81 | 191.97 |
Net Income Net Income Growth | 124.37 | 95.72 | 36.4 | 58.77 | 107.39 | 163.39 |
Earnings Per Share EPS Growth | 0.22 | 0.17 | 0.06 | 0.10 | 0.19 | 0.28 |
EPS Growth | 75.52% | 183.33% | -40.00% | -47.37% | -32.14% | -9.68% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 363.42 | 394.41 | 344.77 | 401.1 | 278.29 | 326.84 |
Total Debt Total Debt Growth | 0.51 | 1.15 | 2.18 | 0.4 | 1.41 | - |
Net Cash (Debt) Net Cash Growth | 362.91 | 393.25 | 342.6 | 400.7 | 276.88 | 326.84 |
Net Cash Growth | -7.31% | 14.79% | -14.50% | 44.72% | -15.29% | 6.96% |
Net Cash Per Share Net Cash Per Share Growth | 0.65 | 0.70 | 0.56 | 0.68 | 0.49 | 0.56 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 141.16 | 128.53 | 91.51 | 129.25 | 185.26 | 200.12 |
Capital Expenditures CapEx Growth | -1.74 | -0.86 | -3.82 | -2.72 | -6.77 | -19.08 |
Free Cash Flow Free Cash Flow Growth | 139.42 | 127.66 | 87.69 | 126.53 | 178.49 | 181.04 |
Free Cash Flow Growth | 5.45% | 45.59% | -30.70% | -29.11% | -1.41% | 27.13% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 77.05% | 75.14% | 72.40% | 74.19% | 74.85% | 77.20% |
Operating Margin | 16.64% | 10.95% | 4.85% | 5.17% | 10.03% | 20.36% |
Pretax Margin | 18.46% | 12.53% | 5.58% | 6.01% | 10.92% | 20.15% |
Profit Margin | 15.92% | 11.72% | 4.77% | 6.46% | 10.58% | 17.33% |
FCF Margin | 17.85% | 15.63% | 11.48% | 13.91% | 17.59% | 19.20% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.292 | 0.266 | - | 0.250 | - | 0.260 |
Dividend Per Share Growth | 119.17% | - | - | - | - | 0% |
Dividend Yield | 4.77% | 4.26% | - | 4.12% | - | 3.51% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 27.61 | 37.63 | 75.79 | 59.62 | 33.33 | 26.14 |
P/FCF Ratio | 25.34 | 28.21 | 31.47 | 27.69 | 20.05 | 23.59 |
PS Ratio | 4.52 | 4.41 | 3.61 | 3.85 | 3.53 | 4.53 |